Lemonaid Health Financial Information

Highlights

• Funding Rounds 5

• Total Funding Amount $57.5M

• Lead Investors 3

• Investors 16

Funding
Lemonaid Health has raised a total of $57.5M in funding over 5 rounds. Their latest funding
was raised on Jul 31, 2020 from a Series B round. Lemonaid is funded by 16 investors. Sierra
Ventures and OTV are the most recent investors.

An online telemedicine platform provider designed to bring patients affordable healthcare. The
company’s online telemedicine platform captures details of medical history, symptoms, current
medicines and allergies and provides a prescription using evidence-based guidelines, enabling users to
improve, quality care that is accessible and available at low cost.

Revenue:
2018 Report: $4.7 million Lemonade Health directly provides telemedicine care and monthly
medicines to customers. Its app emphasizes ease of use, and includes general illness care as well as
counselling and lab test support.
2017 Report: It raised $11 million from the series funding in 2017 and reported three-year growth of
868%. Lemonade Health's estimated annual revenue is currently $24.6 million per year.

Cash Flow Statement

Operating Activities

Fiscal year is
January-December. All
values USD Thousands. 2020 2019 2018 2017

Funds from
-95,900.00 -103,200.00 -50,500.00 -19,700.00 -
Operations
 Funds from
Operations 7.07% -104.36% -156.35% 0.00% -
Growth

Changes in Working
Capital 4,200.00 25,100.00 9,700.00 600 -

Other
4,200.00 25,100.00 9,700.00 600 -
Assets/Liabilities

Net Operating Cash

-91,700.00 -78,100.00 -40,800.00 -19,100.00 -
Flow

Net Operating
Cash Flow -17.41% -91.42% -113.61% 0.00% -
Growth

Investing Activities
All values USD
Thousands.
2020 2019 2018 2017 _

Capital Expenditures -4,400.00 -3,300.00 -700 -300 -

Capital
Expenditures -4,400.00 -2,700.00 -700 -300 -
(Fixed Assets)

Capital
Expenditures - -600 - - -
(Other Assets)

Capital
Expenditures -33.33% -371.43% -133.33% 0.00% -
Growth

Purchase/Sale of
54,500.00 -50,700.00 7,100.00 -12,400.00 -
Investments

Purchase of
-17,800.00 -72,700.00 -13,800.00 -28,000.00 -
Investments

Sale/Maturity of
Investments 72,300.00 22,000.00 20,900.00 15,600.00 -

Net Investing Cash

50,100.00 -54,000.00 6,400.00 -12,700.00 -
Flow

Net Investing
Cash Flow 192.78% -943.75% 150.39% 0.00% -
Growth

Financing Activities

All values USD

Thousands. 2020 2019 2018 2017 _
Change in Capital
Stock 341,100.00 300,100.00 119,900.00 800 -
 Sale of Common
341,100.00 300,100.00 119,900.00 800 -
& Preferred Stock

Proceeds from
Stock Options 339,300.00 299,400.00 119,800.00 800 -

Other
Proceeds from
Sale of 1,800.00 700 100 - -
Stock
Net Financing Cash
Flow 341,100.00 300,100.00 119,900.00 800 -

Net Financing
Cash Flow 13.66% 150.29% 14887.50% 0.00% -
Growth

Exchange Rate Effect 1,600.00 -100 - - -

Net Change in Cash 301,100.00 167,900.00 85,500.00 -31,000.00 -

Free Cash Flow -96,100.00 -80,800.00 -41,500.00 -19,400.00 -

Free Cash Flow

-18.94% -94.70% -113.92% 0.00% -
Growth

Free Cash Flow

-2.33% - - - -
Yield

Balance Sheet
Assets

Fiscal year is
January-December. All
values USD Thousands. 2020 2019 2018 2017
Cash Only 571,400.00 270,300.00 102,400.00 16,900.00 -

Cash Growth 111.39% 163.96% 505.92% 0.00% -

Total Investment
Assets 6,600.00 60,600.00 9,200.00 16,300.00 -

Total Fixed
Income
Securities 6,600.00 60,600.00 9,200.00 16,300.00 -
Investment

Bonds 6,600.00 60,600.00 9,200.00 16,300.00 -

Investments
-89.11% 558.70% -43.56% 0.00% -
Growth

Yield On
Investment 4.46% - - - -

Premium Balance
Receivables 91,500.00 54,100.00 25,900.00 5,900.00 -

Premium
69.13% 108.88% 338.98% 0.00% -
Balance Growth
Net Property, Plant &
Equipment 5,700.00 3,100.00 1,000.00 300 -

Other Assets
13,200.00 4,900.00 2,000.00 1,100.00 -
(Including Intangibles)

Deferred Charges 11,000.00 2,800.00 1,300.00 400 -

Tangible Other
Assets 1,600.00 1,500.00 700 700 -

Intangible Assets 600 600 - - -

Total Assets 688,400.00 393,000.00 140,500.00 40,500.00 -

Assets - Total - 1
Year Growth 75.17% 179.72% 246.91% 0.00% -

Return On
-22.62% - - - -
Average Assets

Liabilities & Shareholders' Equ

All values USD

Thousands.
2020 2019 2018 2017

Insurance Policy
29,800.00 74,900.00 27,500.00 4,700.00 -
Liabilities (Insurance)

Unearned
Premiums 32,500.00 67,000.00 26,200.00 5,600.00 -

Policy Claims -2,700.00 7,900.00 1,300.00 -900 -

Total Debt / Total

Assets 0.00% 0.00% 0.00% 0.00% -
_
Provision for Risks &
Charges - 1,000.00 200 200 -

Other Liabilities 117,600.00 19,400.00 11,100.00 3,600.00 -

Other Liabilities
(excl. Deferred 95,200.00 19,400.00 11,100.00 3,600.00 -
Income)

Deferred Income 22,400.00 - - - -

Total Liabilities 147,400.00 95,300.00 38,800.00 8,500.00 -

Total Liabilities
Growth 54.67% 145.62% 356.47% 0.00% -

Preferred Stock
(Carrying Value) - 480,200.00 180,800.00 60,400.00 -

Non-
Redeemable - 480,200.00 180,800.00 60,400.00 -
Preferred Stock

Common Equity
541,000.00 -182,500.00 -79,100.00 -28,400.00 -
(Total)

Additional PaidIn
Capital/Capital 859,800.00 15,700.00 10,700.00 8,500.00 -
Surplus

Retained
-320,600.00 -198,300.00 -89,800.00 -36,900.00 -
Earnings
 Other
Appropriated 1,800.00 100 - - -
Reserves

Common Equity /
0.79% -0.46% -0.56% -0.70% -
Total Assets

Total Shareholders'
541,000.00 297,700.00 101,700.00 32,000.00 -
Equity

Total
Shareholders'
Equity / Total 78.59% 75.75% 72.38% 79.01% -
Assets

Return On
Average Total -29.16% - - - -
Equity
Total Equity 541,000.00 297,700.00 101,700.00 32,000.00 -

Liabilities &
688,400.00 393,000.00 140,500.00 40,500.00 -
Shareholders' Equity